Peri & Post Approval Services

From Real World Research to Observational Studies

Peri & Post Approval Services

From Real World Research to Observational Studies

Real-World Research for Real-World Outcome
Exom combines multi-disciplinary expertise, and integrated technologies to help you to produce the real-world evidence you need to build your brand value and establish a strong market position,  while maintaining regulatory compliance.

Late phase clinical trials
Our dedicated late-phase CRO services include “full service” support for interventional Phase IIIb and Phase IV studies, peri and post-marketing observational studies, pragmatic trials, post-authorization safety studies (PASS), post-authorization efficacy studies (PAES) to evaluate  effectiveness and safety in a real-world setting.

Observational studies
Observational studies provide valuable insights into the causal association between a treatment (e.g. a drug product, device, or procedure) and a particular event or outcome (e.g. long-term effectiveness and safety).
The non-interventional studies have become critical tools in health care research because they offer a broader range of approaches to answering important, “real world” clinical research and product usage questions.

Corporate Vision MagazineAward Winner

Exom is proud to announce that Corporate Vision Magazine has awarded us the 2021 Corporate Excellence Award as "Most innovative Full-Service CRO" for our technology-driven approach to clinical trial management.

Share This